Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Express 2010
Issue number 855: March 8, 2010
Please click here to subscribe to IAC Express as well as other FREE IAC periodicals.
Contents of this Issue
Select a title to jump to the article.
  1. CDC posts provisional recommendations for universal inactivated influenza vaccination in the 2010-11 U.S. influenza season
  2. CDC posts provisional recommendations for the use of 13-valent pneumococcal conjugate vaccine among infants and children
  3. New: CDC publishes VISs for licensed Japanese encephalitis vaccine--one VIS for Ixiaro and one for JE-VAX
  4. Two more healthcare organizations join IAC's Honor Roll for Patient Safety
  5. FDA advisory panel selects viruses for influenza vaccines to be used in the U.S. during the 2010-11 influenza season
  6. IAC's Video of the Week features a boy's positive perspective on the benefits of influenza vaccination
  7. Keep vaccinating against H1N1 influenza!
  8. CDC has resource to help providers talk with parents about vaccines
  9. IAC corrects inaccurate age indication for PCV13 vaccine that appeared in the March 1 issue of IAC Express
  10. MMWR publishes a report on respiratory syncytial virus activity in the U.S. during July 2008-December 2009
  11. Reminder: Deadline for regular registration for National Immunization Conference is April 2
  12. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention publishes its Strategic Plan for 2010-15
  13. Scheduled for April 24, World Meningitis Day is a day of action to raise awareness about meningitis and septicemia
  14. NFID's Annual Conference on Vaccine Research planned for April 26-28 in Bethesda; early registration deadline is March 15
 
Abbreviations
AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD, National Center for Immunization and Respiratory Diseases; NIVS, National Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
  
Issue 855: March 8, 2010
1.  CDC posts provisional recommendations for universal inactivated influenza vaccination in the 2010-11 U.S. influenza season

On March 2, CDC posted provisional recommendations for use of inactivated influenza vaccines during the 2010-11 U.S. influenza season. Posted on the ACIP web section, provisional recommendations are those ACIP has voted on but that are not yet approved by CDC or the Department of Health and Human Services and have not yet been published in MMWR. The tentative publication of these recommendations in MMWR is June 2010.

In the provisional recommendations, ACIP recommends that beginning in the 2010-11 influenza season, all people ages 6 months and older receive annual influenza vaccination.

To access the complete inactivated influenza vaccines provisional recommendations, go to:
http://www.cdc.gov/vaccines/recs/provisional/downloads/flu-vac-mar-2010-508.pdf

All provisional ACIP recommendations can be found at
http://www.cdc.gov/vaccines/recs/provisional

To access all final ACIP recommendations, go to: http://www.immunize.org/acip IAC's ACIP web section allows visitors to sort documents by date, vaccine, and topic. Bookmark this link for easy access to all provisional and final ACIP recommendations.

Back to top
   
2 CDC posts provisional recommendations for the use of 13-valent pneumococcal conjugate vaccine among infants and children

On March 3, CDC posted provisional recommendations for use of 13-valent pneumococcal conjugate vaccine (PCV13) in infants and children. Posted on the ACIP web section, provisional recommendations are those ACIP has voted on but that are not yet approved by CDC or the Department of Health and Human Services and have not yet been published in MMWR. The scheduled publication date of these recommendations in MMWR is March 12, 2010.

In the provisional recommendations, ACIP recommends PCV13 for all children ages 2 through 59 months and for children ages 60 through 71 months who have underlying medical conditions that increase their risk of pneumococcal disease or complications.

To access the complete PCV13 provisional recommendations, go to:
http://www.cdc.gov/vaccines/recs/provisional/downloads/pcv13-mar-2010-508.pdf

All provisional ACIP recommendations can be found at
http://www.cdc.gov/vaccines/recs/provisional

To access all final ACIP recommendations, go to: http://www.immunize.org/acip IAC's ACIP web section allows visitors to sort documents by date, vaccine, and topic. Bookmark this link for easy access to all provisional and final ACIP recommendations.

Back to top
   
3 New: CDC publishes VISs for licensed Japanese encephalitis vaccine--one VIS for Ixiaro and one for JE-VAX

On March 1, CDC published two VISs--one for each of the two Japanese encephalitis (JE) vaccines licensed for use in the United States. One VIS is intended for use when administering Ixiaro (Intercell Biomedical) and the other when administering JE-VAX (sanofi pasteur). Ixiaro is intended for use in people ages 17 years and older in certain situations. JE-VAX is the only JE vaccine licensed for use in children and adolescents younger than age 17 years in certain situations.

To access the 3/1/10 VIS for Ixiaro Japanese encephalitis vaccine from the IAC website, go to:
http://www.immunize.org/vis/je_ixiaro.pdf

To access the 3/1/10 VIS for JE-VAX Japanese encephalitis vaccine from the IAC website, go to:
http://www.immunize.org/vis/je_vax.pdf

For information about the use of VISs, and for VISs in more than 35 languages, visit IAC's VIS web section at http://www.immunize.org/vis

For general information about VISs from CDC's website go to:
http://www.cdc.gov/vaccines/pubs/vis

Back to top
   
4 Two more healthcare organizations join IAC's Honor Roll for Patient Safety

IAC encourages qualifying healthcare organizations to apply for its Honor Roll for Patient Safety. Since February 22, when IAC Express last reported on the Honor Roll for Patient Safety, two hospitals enrolled. The honor roll recognizes medical practices, hospitals, professional organizations, and government entities that have taken a stand for patient safety by strengthening mandatory influenza vaccination policies for healthcare workers.

The hospitals that have joined since February 22 are Petaluma Valley Hospital, Petaluma, CA, and Santa Rosa Memorial Hospital, Santa Rosa, CA. The addition of these two healthcare organizations brings the total number of enrolled institutions and medical practices to 49.

To be included in the honor roll, an organization's mandate must require influenza vaccination for employees and must include serious measures to prevent transmission of influenza from unvaccinated workers to patients. Such measures might include a mask requirement, reassignment to non-patient-care duties, or dismissal of the employee.

To find out specific information on the mandates of the enrolled organizations, go to: http://www.immunize.org/laws/influenzahcw.asp This web page also includes information about how to apply to be included on the honor roll.

Back to top
   
5 FDA advisory panel selects viruses for influenza vaccines to be used in the U.S. during the 2010-11 influenza season

On February 22, FDA's Vaccines and Related Biological Products Advisory Committee selected the influenza viruses for the composition of the influenza vaccine for the 2010-11 U.S. influenza season. The committee recommended that influenza vaccines contain the following:

  • An A/California/7/09 (H1N1)-like virus; *
  • An A/Perth /16/2009 (H3N2)-like virus; **
  • A B/Brisbane/60/2008-like virus. ***

The influenza vaccine composition to be used in the 2010-11 influenza season in the U.S. is identical to that recommended by the World Health Organization for use during the northern hemisphere 2010-11 influenza season.

* A/California/7/09 (H1N1)-like virus is the pandemic (H1N1) 2009 influenza virus. A monovalent vaccine containing this strain was made available to the United States in fall 2009.

** A/Perth/16/2009 (H3N2)-like virus is a change from the 2009-10 influenza vaccine formulation.

*** B/Brisbane /60/2008-like virus is a current vaccine virus.

To access an FDA statement about the viruses selected for influenza vaccines to be used in the U.S. during the 2010-11 influenza season, click here.

Back to top
   
6 IAC's Video of the Week features a boy's positive perspective on the benefits of influenza vaccination

IAC encourages IAC Express readers to watch a 2-minute animated video that presents the benefits of influenza vaccination from a child's perspective. Fast-paced, fact-packed, and fun, the video was developed by Families Fighting Flu.

The video will be available on the home page of IAC's website through March 14. To access it, go to: http://www.immunize.org and click on the image under the words Video of the Week. It may take a few moments for the video to begin playing; please be patient!

Remember to bookmark IAC's home page to view a new video every Monday. To view an IAC Video of the Week from the past, go to the video archive at http://www.immunize.org/votw

Back to top
   
7 Keep vaccinating against H1N1 influenza!

Please continue to vaccinate patients against H1N1 influenza. Providers who don't have H1N1 influenza vaccine can direct patients to the Google Flu Shot Finder at http://www.google.com/flushot

Back to top
   
8 CDC has resource to help providers talk with parents about vaccines

CDC, in collaboration with the American Academy of Family Physicians and American Academy of Pediatrics, has developed a web section titled Provider Resources for Vaccine Conversations with Parents. It houses materials that can help providers talk with parents about vaccination, as well as fact sheets for providers and parents.

Chief among the materials for providers is a 4-page document, "Talking with Parents about Vaccines for Infants," that offers communication strategies for successful vaccine conversations with parents and caregivers. To access it, go to:
http://www.cdc.gov/vaccines/spec-grps/hcp/downloads/talk-infants-bw-office.pdf

"If You Choose Not to Vaccinate Your Child, Understand the Risks and Responsibilities" is a 2-page fact sheet. To access it, go to:
http://www.cdc.gov/vaccines/spec-grps/hcp/downloads/not-vacc-risks-bw-office.pdf

"Understanding MMR Vaccine Safety," is a 2-page fact sheet for providers and parents. To access it, go to:
http://www.cdc.gov/vaccines/spec-grps/hcp/downloads/vacsafe-mmr-bw-office.pdf

"Measles," a 2-page fact sheet for parents, describes measles symptoms and the benefits and risks of vaccination. It also includes a real-life account about an infant who contracted measles. To access it, go to:
http://www.cdc.gov/vaccines/spec-grps/hcp/downloads/dis-measles-bw-office.pdf

The Provider Resources for Vaccine Conversations with Parents web section is a work in progress, with many more materials planned for inclusion. To access the web section, go to:
http://www.cdc.gov/vaccines/spec-grps/hcp/conversations.htm

Back to top
   
9 IAC corrects inaccurate age indication for PCV13 vaccine that appeared in the March 1 issue of IAC Express

In the March 1 issue of IAC Express, we inadvertently stated that the newly licensed 13-valent pneumococcal conjugate vaccine (PCV 13; Prevnar 13) is indicated for children ages 6 months through 5 years. The accurate age indication is 6 weeks through 5 years.

We regret the error and any confusion it may have caused IAC Express readers.

Back to top
   
10.  MMWR publishes a report on respiratory syncytial virus activity in the U.S. during July 2008-December 2009

CDC published "Respiratory Syncytial Virus Activity--United States, July 2008-December 2009" in the March 5 issue of MMWR. A portion of a summary made available to the press is reprinted below.


Respiratory syncytial virus is the most common cause of bronchiolitis and pneumonia in children aged <1 year worldwide. Each year in the United States, an estimated 75,000-125,000 infants are hospitalized with RSV. Among adults aged >65 years, an estimated 177,000 hospitalizations and 14,000 deaths a year might be attributed to RSV infections. The national 2008-09 RSV season onset occurred the week ending November 1, 2008, and continued for 20 weeks until the week ending March 21, 2009. Knowledge of the RSV season can be used by clinicians and public health officials to determine when to consider RSV as a cause of acute respiratory illnesses and when to provide RSV immunoprophylaxis to children at high risk for serious disease.

To access the full article in web-text (HTML) format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5908a4.htm

Back to top
   
11.  Reminder: Deadline for regular registration for National Immunization Conference is April 2

The National Immunization Conference is scheduled for April 19-22 in Atlanta. The regular registration fee is $250, a $25 savings off the on-site registration fee of $275. The deadline for regular registration is April 2. To register online, go to: http://conferences.taskforce.org/nic10

To get yourself primed for the conference, check out the draft conference agenda. It gives links to abstracts of the presentations that will be made during the conference. To access the abstracts, go to:
http://cdc.confex.com/cdc/nic2010/webprogram/meeting.html

For complete conference details, go to the conference home page at http://www.cdc.gov/vaccines/events/nic

For additional information, contact the Conference Planning Team at (404) 639-8225 or at nipnic@cdc.gov

Back to top
   
12.  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention publishes its Strategic Plan for 2010-15

In February, the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) published its "Strategic Plan for 2010-2015." The plan articulates a vision and overarching goals and strategies to guide and enhance NCHHSTP's programs to prevent HIV/AIDS, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) infections.

To access the plan, click here.

Back to top
   
13.  Scheduled for April 24, World Meningitis Day is a day of action to raise awareness about meningitis and septicemia

The Confederation of Meningitis Organizations (CoMO) urges healthcare professionals, meningitis advocates, and others to join hands on April 24 to make World Meningitis Day a day of action to raise awareness about meningitis and septicemia.

To find out more about World Meningitis Day, go to:
http://www.comoonline.org/wmd.html

To join in a virtual community against meningitis, go to:
http://www.comoonline.org/JoiningHands.aspx

Formed in 2004, CoMO now comprises 26 members and associate members from 19 countries around the world.

To access the CoMO website, go to: http://www.comoonline.org

Back to top
   
14.  NFID's Annual Conference on Vaccine Research planned for April 26-28 in Bethesda; early registration deadline is March 15

The National Foundation for Infectious Diseases' (NFID) Annual Conference on Vaccine Research, the largest scientific forum devoted exclusively to the research and development of vaccines and related technologies for prevention and treatment of disease through immunization, will be held April 26-28 in Bethesda, MD. The early registration deadline is March 15.

For conference details, including online registration, go to: http://www.nfid.org/conferences/vaccine10

For more information, contact the conference planners at (301) 656-0003 or vaccine@nfid.org

Back to top
   
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.